☆ 3.8 Article

New drugs for type 2 diabetes mellitus: The challenge of the health care sustainability combined with a better patient care access

INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Cardiac & Cardiovascular Systems

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

Joshua J. Joseph et al.

Summary: This scientific statement highlights the importance of controlling cardiovascular risk factors in reducing cardiovascular events in patients with diabetes. It analyzes how newer antihyperglycemic agents, blood pressure control, and lipid-lowering therapies can improve glycemic control and prevent cardiovascular disease in diabetes. Additionally, it emphasizes the significance of lifestyle interventions, pharmacological therapy, and surgical interventions in managing obesity and metabolic syndrome, which are important precursors of diabetes and comorbid cardiovascular disease. Furthermore, it explores the critical role of social determinants of health and health equity in the continuum of care for diabetes and cardiovascular disease.

CIRCULATION (2022)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

The Slow Path to Therapeutic Adherence

Francesco Ferrara et al.

Summary: Therapeutic adherence is crucial for the management of chronic conditions. It is necessary for healthcare companies and patients to take action together to improve medication adherence, reducing the negative effects on treatment outcomes and cost.

HOSPITAL PHARMACY (2022)

添加到收藏夹

Letter Pharmacology & Pharmacy

Could Decreased Reporting of Suspected Adverse Reactions Generate Future Safety Concerns?

Francesco Ferrara et al.

HOSPITAL PHARMACY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes JACC Guideline Comparison

Michelle D. Kelsey et al.

Summary: Cardiovascular disease is a major concern for individuals with type 2 diabetes mellitus, and aggressive risk factor management is crucial for these high-risk patients. Recommendations and guidelines from professional societies in cardiology, endocrinology, nephrology, and general medicine in the United States and Europe provide guidance on cardiovascular risk reduction for patients with type 2 diabetes mellitus. While there are some differences in risk stratification, treatment targets for low-density lipoprotein-cholesterol and blood pressure, as well as the use of specific medications, overall there is significant alignment across recommendations from different professional societies.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

添加到收藏夹

Review Endocrinology & Metabolism

Pharmacotherapy of type 2 diabetes: An update and future directions

Antea DeMarsilis et al.

Summary: This review provides an updated summary of the pharmacotherapeutic approach to type 2 diabetes (T2D), including the mechanism of action, administration details, side effect profile, cost, and use in specific populations of different classes of agents. It also reviews the targets of novel therapeutic T2D agent development. Finally, it outlines a contemporary treatment approach starting with the identification of an individualized glycemic control goal, followed by the selection, initiation, and further intensification of a personalized therapeutic plan for T2D.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Vaccines are in short supply amid global cholera surge

Kai Kupferschmidt

SCIENCE (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study

Francesco Ferrara et al.

Summary: This retrospective pharmacovigilance study demonstrates that COVID-19 mRNA vaccines are safe in all population groups.

CLINICAL DRUG INVESTIGATION (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies et al.

Summary: The American Diabetes Association and the European Association for the Study of Diabetes have updated the consensus statements on the management of hyperglycaemia in type 2 diabetes in adults. The new recommendations focus on social determinants of health, physical activity behaviors, and weight management.

DIABETOLOGIA (2022)

添加到收藏夹

Review Medicine, General & Internal

Type 2 diabetes

Ehtasham Ahmad et al.

Summary: Type 2 diabetes accounts for nearly 90% of global diabetes cases, with an increasing number of affected individuals, particularly among young people. Early detection and proactive management are crucial for preventing complications and reducing mortality. Technology and precision medicine offer potential improvements to treatment outcomes but face significant barriers.

LANCET (2022)

添加到收藏夹

Article Immunology

Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view

Francesco Ferrara et al.

Summary: The scientific community is actively searching for new antiviral drugs and therapies to combat SARS-CoV-2. Paxlovid, an oral antiviral, has recently been authorized and has shown good efficacy in reducing the risk of hospitalization in COVID-19 patients. Remdesivir is another authorized antiviral for treating SARS-CoV-2 infection. However, there is still limited data in the literature regarding the safety profile and risk of generating antiviral-resistant variants. This manuscript discusses the monotherapy use of paxlovid and remdesivir, as well as the scientific hypothesis of combining nirmatrelvir and remdesivir to increase treatment efficacy, reduce adverse reactions, and prevent antiviral drug resistance.

INFLAMMOPHARMACOLOGY (2022)

添加到收藏夹

Correction Medicine, General & Internal

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials (vol 372, m4573, 2021)

Palmer

BMJ-BRITISH MEDICAL JOURNAL (2022)

添加到收藏夹

Review Medicine, General & Internal

Cardiogenic Shock After Acute Myocardial Infarction A Review

Marc D. Samsky et al.

Summary: Cardiogenic shock affects 40,000 to 50,000 people in the US annually and is a leading cause of in-hospital mortality post acute myocardial infarction. Immediate revascularization of the infarct-related coronary artery is the primary treatment recommended, supported by clinical trials. Despite lack of definitive evidence, mechanical circulatory support devices are frequently utilized in managing cardiogenic shock.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article

Medicines shortages and the perception of healthcare professionals working in hospitals: An Italian case study

Andrea Zovi et al.

Journal of Interprofessional Education and Practice (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Regional Distribution of Cardiologists and Prescription Patterns of Sodium-Glucose Transporter-2 Inhibitors in Japan

Daisuke Inoue et al.

Summary: The number of certified cardiologists in each region was positively associated with the annual and increased prescription volume of SGLT2 inhibitors, suggesting an early adopter role of these clinical experts in healthcare delivery.

INTERNATIONAL HEART JOURNAL (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Logistics management provides greater efficiency, governance and compliance

Francesco Ferrara et al.

Summary: Direct dispensing (DD) has many advantages over dispensing on commission (DPC), including greater therapeutic appropriateness and cost savings. However, a complex warehouse organization is a major challenge for DD. With the increase in chronic patients and advanced therapies, direct care requires a new structure and logistics system.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map

Jianhong Zhu et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

添加到收藏夹

Review Medicine, General & Internal

Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes A Systematic Review and Network Meta-analysis

Apostolos Tsapas et al.

ANNALS OF INTERNAL MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J. L. Heerspink et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Medicine, Research & Experimental

The Effect of Dipeptidyl Peptidase-4 Inhibitors on Macrovascular and Microvascular Complications of Diabetes Mellitus: A Systematic Review

Olesya M. Taylor et al.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2020)

添加到收藏夹

Review Endocrinology & Metabolism

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

Stephanie A. Amiel et al.

LANCET DIABETES & ENDOCRINOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

V. Perkovic et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Review Endocrinology & Metabolism

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

Brendan L. Neuen et al.

LANCET DIABETES & ENDOCRINOLOGY (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Soren L. Kristensen et al.

LANCET DIABETES & ENDOCRINOLOGY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Global perspectives on ensuring the safety of pharmaceutical products in the distribution process

Sohyun Jeong et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.